Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-4.59
Price to sales ratio
0.3
Dividends per share
0.51
Dividend yield %
4.35

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
1873
HWKN
Hawkins, Inc. - Common Stock
117.67 USD-0.76%-1.99%-17.24%-31.09%2.46 B USD
1890
NGVT
Ingevity Corporation Common Stock
69.70 USD+0.24%+0.22%-5.03%+19.08%2.40 B USD
1903
IOSP
Innospec Inc. - Common Stock
95.34 USD-0.33%+1.74%+11.33%+8.34%2.35 B USD
1929
MTX
Minerals Technologies Inc. Common Stock
72.24 USD+0.26%+1.89%-3.62%+10.83%2.25 B USD

Frequently asked questions about The Chemours Company

What is the The Chemours Company stock price today?

The current price of The Chemours Company (CC) is 15.88. Over the past 24 hours, the stock has changed by +0.70%. Follow the CC chart for real-time price dynamics.

What is the stock ticker of The Chemours Company?

The Chemours Company trades under the ticker CC. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is The Chemours Company stock going up?

CC has changed by +0.06% over the last week, -7.51% over the last month, and +5.10% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of The Chemours Company?

The Chemours Company currently has a market capitalization of 2.39 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

Does The Chemours Company release financial reports?

Yes. You can track The Chemours Company financial reports and review yearly or quarterly fundamentals on metatrader.com, including revenue, net income, dividends, and valuation metrics.

What were The Chemours Company earnings last quarter?

Last quarter, The Chemours Company reported earnings of -1.81 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was The Chemours Company revenue for the last quarter?

The Chemours Company reported quarterly revenue of 1.59 B. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was The Chemours Company net income for the last quarter?

The Chemours Company reported net income of -274 M for the last quarter. The previous quarter showed -29 M, which means net income changed by -844.83%.

Does The Chemours Company pay dividends?

The Chemours Company paid a dividend per share of 0.09. The current dividend yield is 3.78%. Dividend data can help income-focused investors evaluate the stock.

Is The Chemours Company a good dividend stock?

The Chemours Company currently has a dividend yield of 3.78%. Previously, the dividend yield was 3.52%, compared with 4.35% a year earlier. When evaluating dividend stocks, investors should also consider earnings, cash flow, and the sustainability of future dividend payments.

How many employees does The Chemours Company have?

As of the latest available data, The Chemours Company has 5 700 employees. Workforce size can provide additional context about the company's scale and operations.

What is The Chemours Company EBITDA?

The Chemours Company EBITDA is -133 M, and its EBITDA margin is -8.36%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy The Chemours Company stock?

You can buy The Chemours Company (CC) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in The Chemours Company stock?

Investing in The Chemours Company requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the CC chart and related analysis on metatrader.com as part of your research.

Chemours Company Common Stock

The Chemours Company, headquartered in Wilmington, Delaware, is an American chemical company. It was spun off from DuPont in July 2015. The company's primary products are refrigerants, titanium dioxide pigment, and industrial fluoropolymer resins. The company operates 28 major production facilities in 8 countries and serves approximately 2,400 customers in approximately 110 countries. Chemours manufactures and sells chemicals under three divisions: Thermal & Specialized Solutions, which produces refrigerants, thermal management products, propellants, foam blowing agents, and specialty solvents including Freon; Titanium Technologies, which produces titanium dioxide; and Advanced Performance Materials which produces membranes, industrial resins, and coatings under the brand names Teflon, Viton, Nafion, ECCtreme ECA, and Krytox. Chemours is ranked the 594th on the Fortune 500 and 1534th on the Forbes Global 2000. The name of the company is a portmanteau of the words "chemical" and "Nemours", derived from E. I. du Pont de Nemours & Co., the company's former parent. The company has faced fines and regulations from its contamination of air, water, and soil with PFAS.

News